Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score(®) Test in Node-Negative Early Breast Cancer

BACKGROUND: The 21-gene assay (the Oncotype DX Breast Recurrence Score(®) test) is a validated multigene assay which produces the Recurrence Score(®) result (RS) to inform decisions on the use of adjuvant chemotherapy in human epidermal growth factor receptor 2-negative (HER2-), hormone receptor pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Berdunov, Vladislav, Millen, Steve, Paramore, Andrew, Griffin, Jane, Reynia, Sarah, Fryer, Nina, Brown, Rebecca, Longworth, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505370/
https://www.ncbi.nlm.nih.gov/pubmed/36157054
http://dx.doi.org/10.2147/CEOR.S360049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505370/
https://www.ncbi.nlm.nih.gov/pubmed/36157054
http://dx.doi.org/10.2147/CEOR.S360049

Ejemplares similares